← Open Payments lookup

ALEXANDER KORCHMAREV: Open Payments

NPI 1821029042 · SHERMAN OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 28 payments from 7 companies in 2025. Trend: 2023 $690 · 2024 $822 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$238
E.R. Squibb & Sons, L.L.C.5$154
Lundbeck LLC4$116
Otsuka America Pharmaceutical, Inc.4$104
Vanda Pharmaceuticals Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.2$50
Supernus Pharmaceuticals, Inc.1$22

Products named: CAPLYTA, REXULTI, COBENFY, FANAPT, TRINTELLIX, Qelbree.

Industry payments across CA — which companies pay providers there.